Sun LQ - Search Results

1

A marker study of therapeutically transduced CD4+ peripheral blood lymphocytes in HIV discordant identical twins.

Cooper D, Penny R, Symonds G, Carr A, Gerlach W, Sun LQ, Ely J. Cooper D, et al. Among authors: sun lq. Hum Gene Ther. 1999 May 20;10(8):1401-21. doi: 10.1089/10430349950018067. Hum Gene Ther. 1999. PMID: 10365669 Clinical Trial. No abstract available.

2

Preclinical characterization of an anti-tat ribozyme for therapeutic application.

Wang L, Witherington C, King A, Gerlach WL, Carr A, Penny R, Cooper D, Symonds G, Sun LQ. Wang L, et al. Among authors: sun lq. Hum Gene Ther. 1998 Jun 10;9(9):1283-91. doi: 10.1089/hum.1998.9.9-1283. Hum Gene Ther. 1998. PMID: 9650613

3

A phase I trial of autologous CD34+ hematopoietic progenitor cells transduced with an anti-HIV ribozyme.

Amado RG, Mitsuyasu RT, Symonds G, Rosenblatt JD, Zack J, Sun LQ, Miller M, Ely J, Gerlach W. Amado RG, et al. Among authors: sun lq. Hum Gene Ther. 1999 Sep 1;10(13):2255-70. doi: 10.1089/10430349950017239. Hum Gene Ther. 1999. PMID: 10498256 Clinical Trial. No abstract available.

4

Target sequence-specific inhibition of HIV-1 replication by ribozymes directed to tat RNA.

Sun LQ, Wang L, Gerlach WL, Symonds G. Sun LQ, et al. Nucleic Acids Res. 1995 Aug 11;23(15):2909-13. doi: 10.1093/nar/23.15.2909. Nucleic Acids Res. 1995. PMID: 7544887 Free PMC article.

5

Resistance to human immunodeficiency virus type 1 infection conferred by transduction of human peripheral blood lymphocytes with ribozyme, antisense, or polymeric trans-activation response element constructs.

Sun LQ, Pyati J, Smythe J, Wang L, Macpherson J, Gerlach W, Symonds G. Sun LQ, et al. Proc Natl Acad Sci U S A. 1995 Aug 1;92(16):7272-6. doi: 10.1073/pnas.92.16.7272. Proc Natl Acad Sci U S A. 1995. PMID: 7638180 Free PMC article.

6

Anti-HIV ribozymes.

Sun LQ, Ely JA, Gerlach W, Symonds G. Sun LQ, et al. Mol Biotechnol. 1997 Jun;7(3):241-51. doi: 10.1007/BF02740815. Mol Biotechnol. 1997. PMID: 9219238 Review.

7

Ribozymes in gene therapy of HIV-1.

Macpherson JL, Ely JA, Sun LQ, Symonds GP. Macpherson JL, et al. Among authors: sun lq. Front Biosci. 1999 Jun 1;4:D497-505. doi: 10.2741/macpherson. Front Biosci. 1999. PMID: 10352136 Review.

8

Induced p21WAF1 expression acts to reverse myc myelomonocytic cell transformation.

Dolnikov A, Millington M, Sun LQ, Symonds G. Dolnikov A, et al. Among authors: sun lq. Cancer Gene Ther. 2000 Nov;7(11):1491-503. doi: 10.1038/sj.cgt.7700229. Cancer Gene Ther. 2000. PMID: 11129291

9

The use of ribozyme gene therapy for the inhibition of HIV replication and its pathogenic sequelae.

Rigden JE, Ely JA, Macpherson JL, Gerlach WL, Sun LQ, Symonds GP. Rigden JE, et al. Among authors: sun lq. Curr Issues Mol Biol. 2000 Apr;2(2):61-9. Curr Issues Mol Biol. 2000. PMID: 11471565 Free article. Review.

10

Ribozyme-mediated suppression of v-myc expression abrogates apoptosis in transformed monocytes.

Dolnikov A, King A, Luxford C, Symonds G, Sun LQ. Dolnikov A, et al. Among authors: sun lq. Cancer Gene Ther. 1996 Sep-Oct;3(5):289-95. Cancer Gene Ther. 1996. PMID: 8894247

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

263 results

Search Page

Filters